{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:58:08Z","timestamp":1788620288001,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Osteogenesis imperfecta (OI) is a clinically heterogeneous disorder characterised by skeletal fragility and an increased fracture incidence. It occurs in approximately one in every 15\u201320,000 births and is known to vary considerably in its severity. This report aimed to use next-generation sequencing (NGS) technology to identify disease genes and causal variants in South African patients with clinical-radiological features of OI. A total of 50 affected individuals were recruited at Tygerberg Hospital\u2019s Medical Genetics clinic. Patients were selected for a gene panel test (<jats:italic>n<\/jats:italic>\u2009=\u200939), a single variant test (<jats:italic>n<\/jats:italic>\u2009=\u20091) or exome sequencing (ES) (<jats:italic>n<\/jats:italic>\u2009=\u200912, 7 singletons, 1 affected duo, and 1 trio), depending on funding eligibility. An in-house genomic bioinformatics pipeline was developed for the ES samples using open-source software and tools. This study\u2019s 100% diagnostic yield was largely attributable to an accurate clinical diagnosis. A causal variant in <jats:italic>COL1A1<\/jats:italic> or <jats:italic>COL1A2<\/jats:italic> was identified in 94% of this patient cohort, which is in line with previous studies. Interestingly, this study was the first to identify the common South African pathogenic <jats:italic>FKBP10<\/jats:italic> variant in a patient of mixed ancestry, adding to what was previously known about this variant in our population. Additionally, a recurrent variant in <jats:italic>COL1A2<\/jats:italic>: c.1892G&gt;T was discovered in 27 individuals (25 from three large unrelated families and two further individuals), facilitating the establishment of local testing for this variant in South African patients.<\/jats:p>","DOI":"10.1038\/s41431-023-01509-3","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T07:02:12Z","timestamp":1702623732000},"page":"1285-1290","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Genetic basis of osteogenesis imperfecta from a single tertiary centre in South Africa"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2566-0294","authenticated-orcid":false,"given":"Kimberly Christine","family":"Coetzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Z\u00f6llner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4463-3067","authenticated-orcid":false,"given":"Shahida","family":"Moosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"key":"1509_CR1","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/S0140-6736(15)00728-X","volume":"387","author":"A Forlino","year":"2016","unstructured":"Forlino A, Marini JC. Osteogenesis imperfecta. Lancet. 2016;387:1657\u201371.","journal-title":"Lancet"},{"key":"1509_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41588-019-0552-2","volume":"52","author":"GS Baynam","year":"2019","unstructured":"Baynam GS, Groft S, van der Westhuizen FH, Gassman SD, du Plessis K, Coles EP, et al. A call for global action for rare diseases in Africa. Nat Genet. 2019;52:21\u20136.","journal-title":"Nat Genet"},{"key":"1509_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.4103\/2141-9248.131683","volume":"4","author":"BO Edelu","year":"2014","unstructured":"Edelu BO, Ndu IK, Obu HA, Adimora GN, Asinobi IN. Osteogenesis imperfecta: a case report and review of literature. Ann Med Health Sci Res. 2014;4:S1\u20135.","journal-title":"Ann Med Health Sci Res"},{"key":"1509_CR4","unstructured":"Binh H. Osteogenesis imperfecta in Vietnam (dissertation). The University of Tartu; 2017."},{"key":"1509_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000332228","volume":"2","author":"FS van Dijk","year":"2011","unstructured":"van Dijk FS, Cobben JM, Kariminejad A, Maugeri A, Nikkels PGJ, van Rijn RR, et al. Osteogenesis imperfecta: a review with clinical examples. Mol Syndromol. 2011;2:1\u201320.","journal-title":"Mol Syndromol"},{"key":"1509_CR6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.4103\/ijem.IJEM_220_17","volume":"21","author":"JE Sam","year":"2017","unstructured":"Sam JE, Dharmalingam M. Osteogenesis imperfecta. Indian J Endocrinol Metab. 2017;21:903\u20138.","journal-title":"Indian J Endocrinol Metab"},{"key":"1509_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-022-02217-9","volume":"17","author":"SD Frederiksen","year":"2022","unstructured":"Frederiksen SD, Avramovi\u0107 V, Maroilley T, Lehman A, Arbour L, Tarailo-Graovac M. Rare disorders have many faces: In silico characterization of rare disorder spectrum. Orphanet J Rare Dis. 2022;17:1\u201318.","journal-title":"Orphanet J Rare Dis"},{"key":"1509_CR8","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1002\/ajmg.a.62847","volume":"188","author":"S Moosa","year":"2022","unstructured":"Moosa S, Coetzer KC, Lee E, Seo GH. Undiagnosed disease program in South Africa: results from first 100 exomes. Am J Med Genet Part A. 2022;188:2684\u201392.","journal-title":"Am J Med Genet Part A"},{"key":"1509_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"1509_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.7196\/SAMJ.2017.v107i5.9461","volume":"107","author":"A Vorster","year":"2017","unstructured":"Vorster A, Beighton P, Chetty M, Ganie Y, Henderson B, Honey E, et al. Osteogenesis imperfecta type 3 in South Africa: Causative mutations in FKBP10. South Afr Med J. 2017;107:457\u201362.","journal-title":"South Afr Med J"},{"key":"1509_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/540178","volume":"2011","author":"IM Ben Amor","year":"2011","unstructured":"Ben Amor IM, Glorieux FH, Rauch F. Genotype-phenotype correlations in autosomal dominant osteogenesis imperfecta. J Osteoporos. 2011;2011:1\u20139.","journal-title":"J Osteoporos"},{"key":"1509_CR12","doi-asserted-by":"publisher","first-page":"dmm049398","DOI":"10.1242\/dmm.049398","volume":"15","author":"N Garibaldi","year":"2022","unstructured":"Garibaldi N, Besio R, Dalgleish R, Villani S, Barnes AM, Marini JC, et al. Dissecting the phenotypic variability of osteogenesis imperfecta. Dis Model Mech. 2022;15:dmm049398.","journal-title":"Dis Model Mech"},{"key":"1509_CR13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/ahg.12275","volume":"82","author":"M Celin","year":"2018","unstructured":"Celin M, Moosa S, Fano V. Uncommon IFITM5 mutation associated with severe skeletal deformity in osteogenesis imperfecta. Ann Hum Genet. 2018;82:477\u201381.","journal-title":"Ann Hum Genet"},{"key":"1509_CR14","first-page":"37","volume":"1","author":"J Fitzgerald","year":"2013","unstructured":"Fitzgerald J, Holden P, Wright H, Wilmot B, Hata A, Steiner RD, et al. Phenotypic variability in individuals with type v osteogenesis imperfecta with identical IFITM5 mutations. J Rare Disord. 2013;1:37\u201342.","journal-title":"J Rare Disord"},{"key":"1509_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-15-107","volume":"15","author":"S Lazarus","year":"2014","unstructured":"Lazarus S, McInerney-Leo AM, McKenzie FA, Baynam G, Broley S, Cavan BV, et al. The IFITM5 mutation C.-14C>T results in an elongated transcript expressed in human bone; and causes varying phenotypic severity of osteogenesis imperfecta type V. BMC Musculoskelet Disord. 2014;15:107.","journal-title":"BMC Musculoskelet Disord"},{"key":"1509_CR16","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/jbmr.4011","volume":"35","author":"J Dubail","year":"2020","unstructured":"Dubail J, Brunelle P, Baujat G, Huber C, Doyard M, Michot C, et al. Homozygous loss\u2010of\u2010function mutations in CCDC134 are responsible for a severe form of osteogenesis imperfecta. J Bone Miner Res. 2020;35:1470\u201380.","journal-title":"J Bone Miner Res"},{"key":"1509_CR17","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ajhg.2020.09.009","volume":"107","author":"FS van Dijk","year":"2020","unstructured":"van Dijk FS, Semler O, Etich J, K\u00f6hler A, Jimenez-Estrada JA, Bravenboer N, et al. Interaction between KDELR2 and HSP47 as a key determinant in osteogenesis imperfecta caused by bi-allelic variants in KDELR2. Am J Hum Genet. 2020;107:989\u201399.","journal-title":"Am J Hum Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01509-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01509-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01509-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T08:07:40Z","timestamp":1729670860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01509-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1509"],"URL":"https:\/\/doi.org\/10.1038\/s41431-023-01509-3","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]},"assertion":[{"value":"20 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by The Stellenbosch University Health Research Ethics Committee (SU HREC Ref N18\/03\/031). Patients or their legal guardians gave informed consent to participate in the study and publish the results. The informed consent process included an opt-in for secondary findings. The work undertaken in this study was in keeping with the standards stipulated in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}